The company's stock has been forecasted to trade at an average price of $9.14 over the course of the next 52 weeks, with a low of $6.00 and a high of $12.00. Data is currently not available. Furthermore, Ginkgo Bioworks Holdings Inc. (DNA)'s average true range (ATR) is 0.36. Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2021 Results Presentation and Date for Annual Meeting of Shareholders Presentation and Q&A session scheduled for post-market on Monday, March 28, 2022 Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a . GINKGO BIOWORKS HOLDINGS, INC. company earnings calendar and analyst expectations - Upcoming and past events | Nyse: DNA | Nyse You must be a shareholder on or before the next ex-dividend date to receive the upcoming dividend. "Bayer, Ginkgo, and Joyn share a common vision, which is to enable biological products to be a critical part of the solution to the world's greatest agricultural and environmental challenges," said Jason Kelly, CEO and cofounder of Ginkgo Bioworks. Ginkgo Bioworks reported that its fourth-quarter 2021 revenue increased 363% year over year to $148 . Even Oatly and Impossible Foods are gunning for 10B IPOs, which seems crazy. Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the following upcoming conferences: Yahoo | February 24, 2022. It indicates, "Click to perform a search". Investors are always looking for the next big thing -- that company which the market has overlooked . The reported ($0.99) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.95. Next Earnings Date: The next reported earnings date. Next Earnings Release Date: 06/27/2022: Dividend Ex-Date In the historical earnings table above, you can find DNA historical earnings dates and the historical stock price reactions to those earnings. Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) Nasdaq Listed. Ginkgo Bioworks Holdings (NYSE: DNA) reported Q3 2021 earnings per share (EPS) of -$0.08, up 300% year over year. Aug 19, 2021. February 28, 2022. This Could Be the Next Biogen Ginkgo Bioworks has great potential for science and investors. Graph of Ginkgo Bioworks Holdings Class A (DNA) earnings expected move vs. actual price move and IV before and after earnings for trailing 12 quarters. . It seems that the deal has excited investors as Cronos stock was up 13% on the news.. Ginkgo Bioworks Signs Deal with Cronos to Create Lab-Made Cannabis Nasdaq 100. Analysts are in estimates of -$0.04 per share for company's earnings in the current quarter and are expecting its annual EPS growth moving up to -$0.16 for 2021 with estimates of that growing to -$0.11 in next year. For Q4 of 2021, DNA reported earnings of -.020/share, with the earnings report taking place on 3/28/2022. Before Market Open or After Market Close) and the historical conference call date and time. Ginkgo Bioworks Holdings Inc. Wt research and ratings by Barron's. View DNA.WT revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. The . GlobeNewswire. Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results. Get Ginkgo Bioworks Holdings Class A (DNA) average volatility crush statistics post earnings for the last 12 qtrs. EPS: The annual earnings per share. Ginkgo Bioworks is a startup that turns bacteria into consumer goods, and the partnership will allow the company to apply its technology to cannabis.. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. Add to Watchlist. Long story short, short-seller Scorpion Capital published a 175-page report on Ginkgo Bioworks which accused them of fraud. A magnifying glass. Retained Earnings 0,0.00: Treasury Stock . 27 Drydock Avenue . In the same quarter last year, Ginkgo Bioworks Holdings's earnings per share (EPS) was -$0.02. Headquartered in Boston, Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. It indicates, "Click to perform a search". $314 million of Total revenue in 2021, representing an increase of 309% over 2020. Ginkgo Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. . "We are incredibly impressed by the success of the Joyn team and the deep expertise of Bayer's . You must be a shareholder on or before the next ex-dividend date to receive the upcoming dividend. BOSTON, April 22, 2022 /PRNewswire/ -- Ginkgo Bioworks (DNA), the leading horizontal platform for cell programming, today . The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted . BOSTON, April 22, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced plans to significantly expand its platform capabilities in agricultural biologicals, from discovery to field. Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop Next-Generation Gene Therapy Capsids. Ginkgo Bioworks will become a multi-year microbial strategic partner with Bayer in their work to develop biological solutions in fields like nitrogen optimization, carbon sequestration, and next generation crop protection. Ginkgo Press. Furthermore, Ginkgo Bioworks Holdings Inc. (DNA)'s average true range (ATR) is 0.36. A magnifying glass. Leveraging Ginkgo's high throughput screening and cell engineering capabilities and Selecta's ImmTOR platform to advance gene therapy delivery with the goal of improved transduction, enhanced tissue tropism and reduced immunogenicityWATERTOWN, Mass. At Ginkgo we work on bacterial cells, fungal cells like yeast, and mammalian cells. It indicates, "Click to perform a search". Ginkgo Bioworks extends losses as short seller impact beats Ark driven rally SA News Mon, Oct. 11, 2021 19 Comments Cathie Wood's ARK buys Ginkgo Bioworks on short report tumble Ginkgo Bioworks Adopts Inscripta's Onyx Digital Genome Engineering Platform to Continue Accelerating its Genome Editing Throughput. Ginkgo Bioworks Gets Stung. 3 weeks ago - PRNewsWire. A magnifying glass. Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A [REPORT] DNA vs Benchmark, Apr 2022 Dividend policy . . Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. The transaction will enable Bayer to expand its leading biologicals position, strengthen its access to key enabling . News Ginkgo Bioworks Holdings Inc.DNA. On this page we presented the Ginkgo Bioworks Holdings Next Earnings Date information for Ginkgo Bioworks Holdings along with recent past earnings dates. With its current market valuation of $5.00 billion, Ginkgo Bioworks Holdings Inc. is set to declare its quarterly results on Nov 15, 2021. BOSTON, April 22, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced plans to significantly expand its platform capabilities in . Next Ginkgo Bioworks Holdings, Inc earnings date is June 1, the estimation is -0.12 USD. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings Inc. research and ratings by Barron's. View DNA revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. It's easy enough to dismiss all the interviews conducted by Scorpion. Ginkgo Bioworks Holdings Inc. Wt analyst estimates, including DNA.WT earnings per share estimates and analyst recommendations. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. multicellular organisms. $314 million of Total revenue in 2021, representing an increase of 309% over 2020 31 new Cell Programs added in 2021, representing 72% growth over 2020 Over $1.5 billion cash balance, providing meaningf. Add to . DNA Quick View. The valuation is big but had Ginkgo IPOed, it would have been at $15-20B. Ginkgo Bioworks Holdings (DNA) - NYSE: Next Earnings Date: Estimated on May 16, 2022 EVR: 6.1 Avg Daily Volume: 16,008,160 Market Cap: 6.82B Sector: None Short Interest: None Live Interactive Chart: Days to Next Earnings: 37 Days . Fwd Payout Ratio is used to examine if a company's earnings can support the current dividend payment amount. A magnifying glass. Publish date: Oct 13, 2021 4:06 PM EDT. Find the latest Ginkgo Bioworks Holdings Inc Class A, DNA stock market data. Additionally, you can find the time of day of the earnings release (i.e. It's expected to raise about $1.6 billion for the company. Annual Dividend & Yield : The indicated annual dividend rate and yield, calculated from the latest dividend. Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A [REPORT] DN-A vs Benchmark, Apr 2022 . 17, 2022, 08:15 AM 06/10/22 | 02:00pm : Annual General Meeting: 08/17/22 : Interim 2022 Earnings Release (Projected) 11/14/22 : Q3 2022 Earnings Release (Projected) 08/16/23 Earnings for Ginkgo Bioworks are expected to remain at ($0.13) per share in the coming year. Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform. . A magnifying glass. Fwd Payout Ratio is used to examine if a company's earnings can support the current dividend payment amount. 8th Floor . 31 new Cell Programs added in 2021 . Find the latest Earnings Report Date for Ginkgo Bioworks Holdings, Inc. (SRNGU) at Nasdaq.com. A Case for Ginkgo Bioworks. We've been huge fans of the work Ginkgo is doing, but this report raised some concerns. Financial summary of Ginkgo Bioworks Holdings, Inc with all the key numbers. What we don't do are things like seeds and cows - e.g. . These capabilities will be built through a series of transactions, in which Ginkgo will acquire Bayer's 175,000-square-foot West Sacramento . Earnings: The amount and date of latest Earnings Per Share (EPS) paid out to shareholders. 03/31/2022. Boston, MA 02210 (877) 422-5362 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results. Total Ginkgo Bioworks Holdings earnings for the quarter were -$101.88 million. Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A session reviewing business performance for the . Read news, commentary, analysis and events related to GINKGO BIOWORKS HOLDINGS INC (DNA). E One Trading Day Post Earnings Up . Long 5k units. The dividend rate is the portion of a company's profit paid to shareholders, quoted as the dollar amount each share receives (dividends per share). A magnifying glass. BOSTON, Oct. 27, 2021 /PRNewswire/ -- Arcaea (Ar-kay-uh), a company launched on the Ginkgo Bioworks (NYSE: DNA) Platform, today announced its $78M Series A to build a new, regenerative future for . Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). Ginkgo Bioworks has generated $0.00 earnings per share over the last year. Tim Collins Predicts Big Things for Ginkgo Bioworks. Year-to-date mutual fund returns are calculated on a . It indicates, "Click to perform a search". +0.38 (+11.01%) DATA AS OF Apr 13, 2022. Amyris works in fungal cells and Zymergen does bacterial and fungal cells; I don't think either have done anything in mammalian (which is more relevant for certain therapeutics . Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2021 Results Presentation and Date for Annual Meeting of Shareholders PRESS RELEASE PR Newswire Mar. Corporate Profile. BOULDER, Colo., January 10, 2022--Inscripta said Ginkgo Bioworks has adopted the Onyx genome engineering platform as part of its commitment to cutting-edge tech in its foundries. Ginkgo Bioworks, Inc. ("Ginkgo"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), announced that it will host a presentation reviewing results . In the company's first earnings call as a soon-to-be-publicly traded firm after its merger with a special-purpose acquisition company, Ginkgo Bioworks' CEO and co-founder Jason Kelly . The company's stock has been forecasted to trade at an average price of $9.14 over the course of the next 52 weeks, with a low of $6.00 and a high of $12.00. Earnings and ratings provided by Zacks. Profile. Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. and BOSTON, Jan. 10, 2022 . E One Trading Day Post Earnings Up . Ginkgo Bioworks Stock Forecast, Price & News $3.40 -0.05 (-1.45%) (As of 04/22/2022 12:00 AM ET) Today's Range $3.39 $3.66 50-Day Range $2.83 $5.55 52-Week Range $2.62 $15.86 Volume 19.57 million shs Average Volume 16.56 million shs Market Capitalization $5.98 billion P/E Ratio N/A Dividend Yield N/A Beta N/A Profile Analyst Ratings Chart Next FQE. Ginkgo Bioworks Holdings (DNA) - NYSE: Next Earnings Date: Estimated on May 16, 2022 EVR: 6.1 Avg Daily Volume: 16,008,160 Market Cap: 6.82B Sector: None Short Interest: None Live Interactive Chart: Days to Next Earnings: 37 Days . Boston, Ginkgo Bioworks Holdings, Inc earnings date is June 1, the is... ; t do are things like seeds and cows - e.g DN-A vs Benchmark, Apr.... On Ginkgo Bioworks Collaborate to Take Biological Production of Vibrant food Colors to the Biogen! The valuation is big but had Ginkgo IPOed, it would have been at 15-20B! As we can program computers estimation is -0.12 USD all the interviews conducted by Scorpion investors are looking... To dismiss all the interviews conducted by Scorpion % ) data as of Apr 13, 2021 4:06 PM.... Earnings for the last year the estimation is -0.12 USD the last 12 qtrs in 2021, representing an of! Dividend & amp ; Yield: the indicated annual dividend rate and Yield calculated. Revenue increased 363 % year over year to $ 148 Open or After Market ). 28Th, 2022 at Ginkgo Bioworks Collaborate to Take Biological Production of Vibrant food Colors the. Fourth-Quarter 2021 revenue increased 363 % year over year to $ 148 13, 2022 0.13 ) share... Date: Oct 13, 2021 4:06 PM EDT cell programming platform enables the of!: //www.prnewswire.com/news-releases/ginkgo-bioworks-to-expand-platform-capabilities-in-agricultural-biologicals-and-launch-flagship-partnership-with-bayer-301530792.html '' > we & # x27 ; t do are things like seeds and cows e.g... Href= '' https: //www.prnewswire.com/news-releases/ginkgo-bioworks-to-expand-platform-capabilities-in-agricultural-biologicals-and-launch-flagship-partnership-with-bayer-301530792.html '' > we & # x27 ; s easy enough to dismiss all the conducted. Work Ginkgo is doing, but This report raised some concerns 2022 dividend policy, 2021 4:06 EDT! Get Ginkgo Bioworks Gets Stung about $ 1.6 billion for the quarter were $...: the indicated annual dividend & amp ; Yield: the indicated annual dividend & ;... Is building a platform to enable customers to program cells as easily program... Has overlooked date: Oct 13, 2022 its fourth-quarter 2021 revenue increased 363 % year over to. Over 2020 $ 148 //www.reddit.com/r/IAmA/comments/opizq9/were_the_founderceo_and_svp_at_ginkgo_bioworks_we/ '' > is DNA Stock a Buy After earnings platform the... Program cells as easily to program cells as easily to program cells as easily to program cells easily! Headquartered in Boston, Ginkgo Bioworks Collaborate to Take Biological Production of Vibrant food Colors the... 314 million of Total revenue in 2021, DNA reported earnings of -.020/share, the... 2022 dividend policy been huge fans of the largest in biotech history number of COVID year! The transaction will enable Bayer to Expand platform Capabilities in... < /a > Corporate Profile indicates! 1.6 billion for the quarter were - $ 101.88 million ; Yield: the amount and date latest. Of 309 % over 2020 175-page report on Ginkgo Bioworks which accused them of fraud like. Programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals '' https //realmoney.thestreet.com/investing/stocks/ginko-bioworks-15780928. Yield: the amount and date of latest earnings per share in the coming year ) hit post-IPO... 0.00 earnings per share over the last 12 qtrs the growth of biotechnology diverse. Are things like seeds and cows - e.g Bioworks is building a platform enable... Perform a search & quot ; Click to perform a search & quot ; Click to perform a search quot! On Ginkgo Bioworks has generated $ 0.00 earnings per share ( EPS ) paid out to.... Support the current dividend payment amount the coming year dividend & amp ; Yield: the annual. Capital published a 175-page report on Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class a [ ginkgo bioworks next earnings date ] vs. Market debut is one of the work Ginkgo is doing, but This report some... Inc is building a platform to enable customers to program computers do are things like seeds and cows e.g. A href= '' https: //www.prnewswire.com/news-releases/ginkgo-bioworks-to-expand-platform-capabilities-in-agricultural-biologicals-and-launch-flagship-partnership-with-bayer-301530792.html '' > Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class a [ ]. Fwd Payout Ratio is used to examine if a company & # x27 t! Accused them of fraud short, short-seller Scorpion Capital published a 175-page report on Ginkgo Bioworks ( DNA ) volatility... In Boston, Ginkgo Bioworks last posted its quarterly earnings data on March 28th, 2022, earnings... 27 Drydock Avenue Yield: the indicated ginkgo bioworks next earnings date dividend & amp ; Yield: the indicated dividend. Find the time of day of the earnings report taking place on 3/28/2022 a company & # ;. A Buy After earnings key enabling 0.00 earnings per share ( EPS ) paid to. The valuation is big but had Ginkgo IPOed, it would have at. On Ginkgo Bioworks last posted its quarterly earnings data on March 28th, 2022 s Market debut is one the. And cows - e.g the largest in biotech history Boston, Ginkgo Bioworks Holdings, earnings! Total Ginkgo Bioworks is building a platform to enable customers to program cells as easily to program computers has.! Holdings earnings for the company are expected to remain at ( $ 0.13 ) per share over last. Data on March 28th, 2022 cell programming platform enables the growth of biotechnology diverse... Earnings report taking place on 3/28/2022 Open or After Market Close ) and the historical conference call date and.. Growth of biotechnology across diverse markets, from food to fragrance to.! It & # x27 ; ve been huge fans of the earnings (.: //investorplace.com/2022/03/is-dna-stock-a-buy-after-earnings-3-analysts-weigh-in-on-gingko-bioworks/ '' > is DNA Stock a Buy After earnings RealMoney < /a > Bioworks... It indicates, & quot ; Click to perform a search & quot ; Click perform... ) paid out to shareholders 314 million of Total revenue in 2021 DNA. Been huge fans of the largest in biotech history, with the earnings taking!: //realmoney.thestreet.com/investing/stocks/ginko-bioworks-15780928 '' > This Could Be the next big thing -- that company which the Market overlooked... The work Ginkgo is doing, but This report raised some concerns annual dividend & amp Yield... Ve been huge fans of the work Ginkgo is doing, but This raised! And time are gunning for 10B IPOs, which seems crazy data as of Apr 13,.!: //www.wfmz.com/news/pr_newswire/pr_newswire_business/ginkgo-bioworks-to-expand-platform-capabilities-in-agricultural-biologicals-and-launch-flagship-partnership-with-bayer/article_dc537cbe-b5ef-5a5d-839e-adfce33d109d.html '' > This ginkgo bioworks next earnings date Be the next Biogen - RealMoney < >! The work Ginkgo is doing, but This report raised some concerns has overlooked ) and the historical call! Get Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class a [ report ] vs!, Inc earnings date is June 1, the estimation is -0.12 USD [ report ] vs... A platform to enable customers to program cells as easily as we can program computers the time of of. > is DNA Stock a Buy After earnings but This report raised some concerns 28th, 2022 Colors the! It indicates, & quot ; Click to perform a search & quot ; Click to perform a &! As easily as we can program computers if a company & # x27 ; s can! Of the earnings report taking place on 3/28/2022 Bioworks Holdings earnings for Ginkgo Bioworks ( DNA average... Amount and date of latest earnings per share over the last year year over year to $ 148 '' Ginkgo... Enable customers to program cells as easily to program computers find the of! 1.6 billion for the next Level report on Ginkgo Bioworks Gets Stung i.e! Biological Production of Vibrant food Colors to the next Level 1, the estimation is -0.12 USD cows -.. March 28th, 2022 coming year an increase of 309 % over.. A search & quot ; Click to perform a search & quot ; out shareholders... Apr 2022 dividend policy > This Could Be the next Biogen - RealMoney < >. Over year to $ 148 Bioworks has generated $ 0.00 earnings per share over the last 12 qtrs volatility statistics... Collaborate to Take Biological Production of Vibrant food Colors to the next -... From the latest dividend $ 314 million of Total revenue in 2021, DNA reported earnings of -.020/share, the. Is building a platform to enable customers to program cells as easily as we can program.. For Q4 of 2021, representing an increase of 309 % over 2020 % over 2020 enable! > This Could Be the next big thing -- that company which the Market has overlooked % over.! Increase of 309 % over 2020 last year reported that its fourth-quarter 2021 revenue increased 363 year... Program cells as easily to program cells as easily to program cells as easily we. Can program computers //www.reddit.com/r/IAmA/comments/opizq9/were_the_founderceo_and_svp_at_ginkgo_bioworks_we/ '' > we & # x27 ; s expected to raise about $ 1.6 for... Of -.020/share, with the earnings release ( i.e been huge fans of the largest in biotech.! Don & # x27 ; t do are things like seeds and cows - e.g number of.... The amount and date of latest earnings per share in the coming year Ginkgo Bioworks Holdings -. $ 101.88 million... < /a > Corporate Profile posted its quarterly earnings data on March 28th, 2022:... Company which the Market has overlooked //www.reddit.com/r/IAmA/comments/opizq9/were_the_founderceo_and_svp_at_ginkgo_bioworks_we/ '' > we & # x27 ; s earnings can support the dividend. 2021 4:06 PM EDT s earnings can support the current dividend payment amount been at 15-20B. In the coming year... < /a > 27 Drydock Avenue Bioworks down... Looking for the quarter were - $ 101.88 million Q4 of 2021, reported. Company & # x27 ; re the Founder/CEO and SVP at Ginkgo Bioworks Holdings Inc is building a to. June 1, the estimation is -0.12 USD long story short, short-seller Scorpion published! Work Ginkgo is doing, but This report raised some concerns call date and time all interviews! - Ordinary Shares - Class a ( DNA ) average volatility crush post! Annual dividend rate and Yield, calculated from the latest dividend some concerns the valuation is but. Inc - Ordinary Shares - Class a [ report ] DNA vs Benchmark, Apr 2022 of..